Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated StudyPsychiatry Published on 2023-12-132024-09-05 Journal: Cureus [Category] update2024, [키워드] antidepressants Antipsychotics benzodiazepines COVID 19 Drug-drug interactions medication therapy management Mood stabilizers Psychotropic [DOI] 10.7759/cureus.50469 PMC 바로가기 [Article Type] Psychiatry
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique ☆article Published on 2023-06-092024-09-02 Journal: Anais Brasileiros de Dermatologia [Category] 대상포진, [키워드] atopic dermatitis Delphi technique medication therapy management phototherapy [DOI] 10.1016/j.abd.2023.04.003 PMC 바로가기 [Article Type] article
Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failureArticle Published on 2023-04-102024-09-05 Journal: Journal of critical care [Category] update2024, [키워드] Corticosteroids Immunosuppression Interleukins medication therapy management Respiratory failure respiratory infections [DOI] 10.1016/j.jcrc.2023.154291 PMC 바로가기 [Article Type] Article
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection RiskCOVID-19 저산소 호흡기로 입원 한 환자에서 고용량 코르티코 스테로이드가있는 저용량 토 실리 주맙Multicenter Study Published on 2021-06-282022-09-01 Journal: The Annals of Pharmacotherapy [Category] MERS, 진단, [키워드] 28-day mortality 95% CI Adult patients adult respiratory distress syndrome Analysis balance benefit Biomarker Combination combination therapies combination therapy Corticosteroid Corticosteroids COVID-19 COVID-19 pneumonia COVID-19 treatment Dexamethasone dexamethasone 6 mg dosage failure group hazard ratio high mortality hypoxia hypoxic respiratory failure Increased Infection Inflammation Interleukins medication therapy management Modification Mortality objective Patient patients with COVID-19 Pneumonia present reduction in mortality Relative risk Relevance respiratory Respiratory failure respiratory infections Result Retrospective study risk risk of infection Secondary infection severe respiratory failure Standard of care steroid supportive therapy survival therapeutic effect therapy Tocilizumab Treatment was performed were assessed [DOI] 10.1177/10600280211028882 PMC 바로가기 [Article Type] Multicenter Study